Achiko Secures Up To Usd$12.6 Million Equity And Debt Financing Lines With Riverfort Over Three Years

Company

About

The Company has already invested in active compounds and plastics and requires the funds to complete the production of around 1,000,000 test kits for its proprietary aptamer-based Covid-19 testing system, as initial inventory before a larger marketing rollout. The Facilities provide Achiko with increased flexibility to finance its growth over the next three years.” “Achiko immediately presented to us a deep understanding of the continued challenges of both Covid-19 at a global level and the complexities of distribution of the services related to the testing of geographically diverse populations. Headquartered in Zurich, Achiko has offices in Jakarta and Singapore.